Sponsors (7)
The bill strengthens law enforcement's ability to disrupt deadly synthetic drug networks through mandatory reporting and evidence preservation, but it expands data collection and reporting obligations in ways that raise privacy, free‑speech, surveillance, operational, and financial risks for users and providers.
Law enforcement and the public: faster mandatory reporting and preservation of evidence enables quicker investigations and prosecutions of fentanyl, methamphetamine, and counterfeit-drug networks, which can reduce the distribution of deadly synthetic drugs.
Taxpayers and oversight bodies: annual Department of Justice reporting on program use increases transparency about report volumes, sources, and outcomes, enabling public oversight of how the law is implemented.
Users, journalists, security researchers, immigrants, and people with disabilities: mandatory collection and preservation of extensive metadata and account identifiers raises substantial privacy risks and could chill lawful speech, investigative journalism, and security research if data is mishandled or disclosure rules are insufficient.
Tech workers, platform users, and taxpayers: required reporting duties may encourage broader surveillance or reliance on automated detection, increasing false positives, operational burdens on providers, and potential harms to users flagged incorrectly.
Technology providers and their customers: civil and criminal penalties for noncompliance (including large fines) create financial and operational risks for providers that could raise costs, reduce services, or be passed to users.
Based on analysis of 3 sections of legislative text.
Requires certain online service providers to report, preserve, and produce records about specified illicit drug and counterfeit-drug activity to the Attorney General within set timeframes.
Official title: Amend the Controlled Substances Act to require electronic communication service providers and remote computing services to report to the Attorney General certain controlled substances violations.
Introduced July 17, 2025 by Roger Wayne Marshall · Last progress July 17, 2025
Creates new reporting, preservation, and production duties for certain electronic communication service and remote computing providers to notify the Attorney General when they learn or reasonably believe their services are being used to facilitate distribution, manufacture, or sale of fentanyl, methamphetamine, counterfeit drugs (including counterfeit prescription drugs), or unauthorized manufacture/distribution/dispensing of prescription pain medications or stimulants. The law requires timely reports (generally as soon as reasonably possible and no later than 60 days), record retention, and assistance to law enforcement, while directing the Attorney General to issue implementing regulations and authorizing civil penalties and injunctive relief for noncompliance. The bill includes rules about emergency disclosures, limits on use of produced information, notice and procedural protections, timelines for Attorney General regulations, preservation and production procedures, and a severability clause so remaining provisions stay effective if part of the law is held unconstitutional.